RFG Advisory’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,754
Closed -$260K 730
2024
Q1
$260K Hold
2,754
0.01% 637
2023
Q4
$255K Buy
+2,754
New +$211K 0.01% 586
2022
Q4
Sell
-3,475
Closed -$210K 648
2022
Q3
$210K Buy
3,475
+7
+0.2% +$486 0.01% 575
2022
Q2
$237K Buy
3,468
+11
+0.3% +$770 0.01% 507
2022
Q1
$243K Sell
3,457
-277
-7% -$18.6K 0.02% 449
2021
Q4
$254K Buy
3,734
+697
+23% +$48.2K 0.02% 424
2021
Q3
$213K Sell
3,037
-150
-5% -$10.9K 0.02% 399
2021
Q2
$223K Sell
3,187
-1,000
-24% -$72.7K 0.02% 404
2021
Q1
$326K Hold
4,187
0.04% 326
2020
Q4
$305K Sell
4,187
-799
-16% -$52.6K 0.04% 328
2020
Q3
$311K Buy
+4,986
New +$312K 0.04% 305

Other funds holding NHC

RFG Advisory's NHC Position: Q2 2024 in Review

RFG Advisory sold out of National Healthcare (NHC) in Q2 2024, closing a stake of 2,754 shares — an estimated $260K sold.

RFG Advisory first reported a position in NHC in Q3 2020 and held it in 11 quarters. The position peaked at $326K in Q1 2021. 175 funds tracked by Wall St. Rank hold NHC as of Q2 2024.

  • RFG Advisory reported no remaining National Healthcare position as of Q2 2024 after selling out during the quarter.
  • RFG Advisory sold 2,754 National Healthcare shares in Q2 2024, an estimated $260K.
  • RFG Advisory first reported a position in National Healthcare in Q3 2020 and held it in 11 quarters.
  • RFG Advisory's National Healthcare position peaked at $326K in Q1 2021.
  • 175 funds tracked by Wall St. Rank held National Healthcare as of Q2 2024.

Based on RFG Advisory's 13F filing for Q2 2024, filed 15 Jul 2024.